Steve Tutewohl - Mar 1, 2023 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Role
Chief Operating Officer
Signature
/s/ Jonathan Weinberg, Attorney-in-fact
Stock symbol
EVH
Transactions as of
Mar 1, 2023
Transactions value $
-$189,206
Form type
4
Date filed
3/3/2023, 04:42 PM
Previous filing
Feb 23, 2023
Next filing
Apr 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVH Class A Common Stock Award $0 +17K +14.7% $0.00 133K Mar 1, 2023 Direct F1, F2, F3
transaction EVH Class A Common Stock Tax liability -$76.7K -2.18K -1.64% $35.26 131K Mar 1, 2023 Direct F3, F4
transaction EVH Class A Common Stock Tax liability -$112K -3.2K -2.45% $35.15 127K Mar 2, 2023 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units granted to Mr. Tutewohl pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
F2 Securities vest at a rate of 34% on March 1, 2024, and 33% on March 1, 2025, and March 1, 2026.
F3 Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
F4 This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.